cancer panel
Pillar Biosciences, AstraZeneca Partner on Liquid Biopsy Testing in Europe
AstraZeneca has partnered with several other firms on liquid biopsies, including Angle, Sophia Genetics, IMBdx, and Guardant Health.
FDA Approves Illumina Cancer Genomic Profiling Assay as CDx for Kinase Inhibitors From Bayer, Lilly
The test's first CDx approvals are for Bayer's Vitrakvi in solid tumors and for Lilly's Retevmo in non-small cell lung cancer.
Cancer Sequencing Labs, Advocacy Groups Partner to Increase Genetic Testing Access
The newly launched INTERACT coalition said it will try to press medical and industry guidelines to keep pace with evidence surrounding inherited cancer risk.
Thermo Fisher Scientific, Pfizer Canada Grant C$300K to Study NGS in Colorectal Cancer Care
The recipients of both grants will study the effects of bringing next-generation sequencing-based testing into a community cancer center.
A comparison for 144 solid tumor samples showed a "high degree of alignment" with FoundationOne CDx and better calling of CNAs than Illumina's TSO 500.